National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
Trends Pharmacol Sci. 2024 Nov;45(11):958-960. doi: 10.1016/j.tips.2024.09.005. Epub 2024 Oct 2.
Development of protective immune responses relies on a balance between proinflammatory CD4 T helper (Th) cell populations such as Th17 cells and regulatory CD4 T cells (Tregs) that keep immune activation in check. Evidence that interleukin-2-inducible T cell kinase (Itk) regulates this balance supports therapeutic applications for Itk inhibition.
保护性免疫反应的发展依赖于促炎 CD4 T 辅助(Th)细胞群体(如 Th17 细胞)和调节性 CD4 T 细胞(Tregs)之间的平衡,后者可控制免疫激活。白细胞介素 2 诱导的 T 细胞激酶(Itk)调节这种平衡的证据支持 Itk 抑制的治疗应用。